These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Oral budesonide for induction of remission in ulcerative colitis. Sherlock ME; Seow CH; Steinhart AH; Griffiths AM Cochrane Database Syst Rev; 2010 Oct; (10):CD007698. PubMed ID: 20927762 [TBL] [Abstract][Full Text] [Related]
27. A safety evaluation of budesonide MMX for the treatment of ulcerative colitis. Bezzio C; Festa S; Zerboni G; Papi C; Manes G; Saibeni S Expert Opin Drug Saf; 2018 Apr; 17(4):437-444. PubMed ID: 29473429 [TBL] [Abstract][Full Text] [Related]
29. Treatment of mild persistent asthma in children. Levy ML Lancet; 2011 May; 377(9779):1743; author reply 1744. PubMed ID: 21601698 [No Abstract] [Full Text] [Related]
30. Nanotherapeutics for the treatment of inflammatory bowel disease. Chen Q; Xiao B; Merlin D Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):495-497. PubMed ID: 28317404 [No Abstract] [Full Text] [Related]
31. [Clinical effectiveness of various budesonide preparations in Crohn disease]. Schölmerich J Med Klin (Munich); 1999 Feb; 94 Suppl 1():30-8. PubMed ID: 10194946 [TBL] [Abstract][Full Text] [Related]
32. Contact allergy to budesonide and perforation of the nasal septum. Isaksson M; Bruze M; Wihl JA Contact Dermatitis; 1997 Sep; 37(3):133. PubMed ID: 9330826 [No Abstract] [Full Text] [Related]
33. [Budesonide foam as a new therapeutic principle in distal ulcerative colitis in comparison with mesalazine enema. An open, controlled, randomized and prospective multicenter pilot study]. Rufle W; Frühmorgen P; Huber W; Kimmig JM Z Gastroenterol; 2000 Apr; 38(4):287-93. PubMed ID: 10820860 [TBL] [Abstract][Full Text] [Related]
34. [Drug therapy of Crohn's disease: slowly increase or start aggressively right away?]. Bischoff A MMW Fortschr Med; 2010 Jan; 152(1-2):20. PubMed ID: 20302159 [No Abstract] [Full Text] [Related]
35. Oral budesonide therapy for steroid-dependent ulcerative colitis: a pilot trial. Keller R; Stoll R; Foerster EC; Gutsche N; Domschke W Aliment Pharmacol Ther; 1997 Dec; 11(6):1047-52. PubMed ID: 9663828 [TBL] [Abstract][Full Text] [Related]
36. Effect of mizoribine in children with inflammatory bowel disease. Fujii T; Ohtsuka Y; Yamakawa Y; Ohtani K; Kudo T; Ohtomo Y; Nagata S; Shimizu T Pediatr Int; 2010 Feb; 52(1):e57-9. PubMed ID: 20158652 [No Abstract] [Full Text] [Related]
37. [Budesonide: effective, with low side effects. On the road to new treatment methods in Crohn disease]. Internist (Berl); 1998 Sep; 39(9 Suppl Auf Dem We):1-8. PubMed ID: 9772715 [No Abstract] [Full Text] [Related]
38. Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group. Hanauer SB; Robinson M; Pruitt R; Lazenby AJ; Persson T; Nilsson LG; Walton-Bowen K; Haskell LP; Levine JG Gastroenterology; 1998 Sep; 115(3):525-32. PubMed ID: 9721148 [TBL] [Abstract][Full Text] [Related]